As the second largest biopharmaceutical market, China presents tremendous opportunity, but companies will need to mature medical affairs teams quickly as the market continues to evolve. To strengthen their medical affairs teams, pharmaceutical companies will need to be creative with their physician and stakeholder engagement models, as well as cultivating the local talent.

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.